Chemoprevention of 4-nitroquinoline 1-oxide-induced rat oral carcinogenesis by the dietary flavonoids chalcone, 2-hydroxychalcone, and quercetin

Cancer Research

Volumn 56, Issue 21, 1996, Pages 4904-4909

  Makita, Hiroki ^a   Tanaka, Takuji ^a   Fujitsuka, Hideki ^a   Tatematsu, Norichika ^a   Satoh, Kumiko ^b   Hara, Akira ^b   Mori, Hideki ^a  

^a GIFU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b GIFU PHARMACEUTICAL UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

2 HYDROXYCHALCONE; 4 NITROQUINOLINE 1 OXIDE; CHALCONE; DRINKING WATER; FLAVONOID; QUERCETIN; UNCLASSIFIED DRUG;

ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CANCER INHIBITION; CANCER PREVENTION; CELL PROLIFERATION; CHEMICAL CARCINOGENESIS; CONTROLLED STUDY; DIETARY INTAKE; MALE; MOUTH CANCER; MOUTH MUCOSA; NONHUMAN; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; RAT; TONGUE CANCER;

4-NITROQUINOLINE-1-OXIDE; ANIMALS; ANTICARCINOGENIC AGENTS; BIOGENIC POLYAMINES; BODY WEIGHT; BROMODEOXYURIDINE; CHALCONE; CHALCONES; MALE; MOUTH NEOPLASMS; PRECANCEROUS CONDITIONS; QUERCETIN; RATS; RATS, INBRED F344;

EID: 0029946420     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (70)

1. Jovanoic, A., Schulten, E. A. J. M., Kostense, G. B., and van der Waal, I. Tobacco and alcohol related to the anatomical site of oral squamous cell carcinoma J. Oral Pathol. Med., 22: 459-462, 1993.
2. Blot, W. J., McLaughlin, J. K., Winn, D. M., Austin, D. F., Greenberg, R. S., Preston-Martin, S., Bernstein, L., Schoenberg, J. B., Stemhargen, A., and Fraumeni, J. F. J. Smoking and drinking in relation to oral and pharyngeal cancer. Cancer Res., 48: 3282-3287, 1988.
3. Mashberg, A., Boffetta, P., Winkleman, R., and Garfinkel, L. Tobacco smoking, alcohol drinking, and cancer of the oral cavity and oropharynx among U. S. veterans. Cancer (Phila.), 72: 1369-1375, 1993.
4. Licciardello, J. T. W., Spitz, M. R., and Hong, W. K. Multiple primary cancer in patients with cancer of the head and neck second cancer of the head and neck, esophagus and lung. Int. J. Radiat. Oncol. Biol. Phys., 17: 467-476, 1989.
5. Lippman, S. M., and Hong, W. K. Second malignant tumors in head and neck squamous cell carcinoma: the overshadowing threat for patients with early-stage disease. Int. J. Radiat. Oncol. Biol. Phys., 17: 691-694, 1989.
6. Franco, E. L., Kowalski, L. P., and Kanda, J. L. Risk factors for second cancers of the upper respiratory and digestive system: a case-control study. J. Clin. Epidemiol., 44: 615-625, 1991.
7. Hays, G. L., Lippman, S. M., Flaitz, C. M., Brown, R. S., Pang, A., Devoll, R., and Hong, W. K. Co-carcinogenesis, and field cancerization: oral lesions offer first signs. J. Am. Dent. Assoc., 126: 47-51, 1995.
8. Slaughter, D. P., Southwick, H. W., and Smejkal, W. Field cancerization in oral stratified squamous epithelium: clinical implications of multicentric origin Cancer (Phila.), 6: 963-968, 1953.
9. Sporn, M. Approaches to prevention of epithelial cancer during the preneoplastic period. Cancer Res., 36: 2699-2702, 1976.
10. Wellenberg, L. W. Chemoprevention of cancer by naturally occurring and synthetic compounds In: L. W. Wattenberg, M. Lipkin, C. W. Boone, and G. J. Kelloff, (eds.), Cancer Chemoprevention, pp 19-39. Boca Raton, FL: CRC Press, Inc., 1992.
11. Tanaka, T. Cancer chemoprevention. Cancer J., 5: 11-16, 1992.
12. Shklar, G., Marefat, P., Kornhouser, A., Trickler, D. P., and Wallace, K. D. Retinoid inhibition of lingual carcinogenesis. Oral Surg. Oral Med. Oral Pathol., 49: 325-332, 1980.
13. Stinson, S. P. Reznik, G., and Donahoe, R. Effect of three retinoids on tracheal carcinogenesis with N-methyl-N-nitrosourea in hamsters. J. Natl. Cancer Inst., 66: 947-951, 1981.
14. Shklar, G., Schwartz, J., Grau, D., Trickler, D. P., and Wallace, K. D. Inhibition of hamster buccal pouch carcinogenesis by 13-cis-retinoic acid Oral Surg. Oral Med. Oral Pathol., 50: 45-52, 1980.
15. Fountzilas, G. Retinoids in the management of head and neck cancer: an update. J. Chemother., 6: 127-138, 1994.
16. Boone, C. W., Kelloff, G. J., and Malone, W. E. Identification of candidate cancer chemopreventive agents and their evaluation in animal models and human clinical trials, a review Cancer Res., 50: 2-9, 1990.
17. Meyskens, F. L., Jr. Biology and intervention of the premalignant process Cancer Bull., 43: 475-480, 1991.
18. Boone, C. W., Kelloff, G. I., and Steele, V. Histopathology of the premalignant process. Cancer Bull., 1991: 481-484, 1991.
19. Tanaka, T. Chemoprevention of oral carcinogenesis, Eur. J. Cancer Oral Oncol., 31B: 3-15, 1995.
20. Nauta, J. M., Roodenburg, L. N., Nikkels, P. G. I., Witjes, M. J. H., and Vermey, A. Comparison of epithelial dysplasia-the 4NQO rat palate model and human oral mucosa. Int J Oral Maxillofac Surg., 24: 53-58, 1995.
21. Tanaka, T., Nishikawa, A., Mori, Y., Morishita, Y., and Mori, H. Inhibitory effects of non-steroidal anti-inflammatory drugs, piroxicam and indomethacin on 4-nitroquinoline 1-oxide-induced tongue carcinogenesis in male ACI/N rats Cancer Lett. 48: 177-182, 1989.
22. Tanaka, T., Kojima, T., Morishita, Y., and Mori, H. Inhibitory effects of the natural products indol-3-carbinol and sinigrin during initiation and promotion phases of 4-nitroquinoline 1-oxide-induced rats tongue carcinogenesis Jpn. J. Cancer Res., 83: 835-842, 1992.
23. Tanaka, T., Kojima, T., Kawamori, T., Wang, A., Suzui, M., and Okamoto, K. Inhibition of 4-introquinoline 1-oxide-induced rat tongue carcinogenesis by the naturally occurring plant phenolics caffeic, ellagic, chlorogenic, and ferulic acids Carcinogenesis (Lond.), 14: 1321-1325, 1993.
24. Tanaka, T., Kojima, T., Hara, A., Sawada, H., and Mori, H. Chemoprevention of oral carcinogenesis by DL-α-difluoromethylornithine, an ornithine decarboxylase inhibitor dose-dependent reduction in 4-nitroquinoline 1-oxide-induced tongue neoplasms in rats. Cancer Res., 53: 772-776, 1993.
25. Tanaka, T., Kawamori, T., Ohnishi, M., Okamoto, K., Mori, H., and Hara, A. Chemoprevention of 4-nitroquinoline 1-oxide-induced oral carcinogenesis by dietary protocatechuic acid during initiation and postinitiation phases. Cancer Res., 54: 2359-2365, 1994.
26. Tanaka, T., Makita, H., Ohnishi, M., Hirose, Y., Wang, A., Mori, H., Satoh, K., Hara, A., and Ogawa, H. Chemoprevention of 4-nitroquinoline 1-oxide oral carcinogenesis by dietary curcumin and hesperidin: comparison with the protective effect of β-carotene. Cancer Res., 54: 4653-4659, 1994.
27. Tanaka, T., Makita, H., Ohnishi, M., Mori, H., Satoh, K., and Hara, A. Inhibition of carcinogenesis by the arotinoid mofarotene (Ro 40-8757) in male F344 rats. Carcinogenesis (Lond.), 16: 1903-1907, 1995.
28. Makita, H., Tanaka, T., Ohnishi, M., Tamai, Y., Torihara, M., Yamahara, J., Mori, H., Satoh, K., and Hara, A. Inhibition of 4-nitroquinoline-1-oxide-induced rat oral carcinogenesis by dietary exposure of a new retinoidal butenolide, KYN-54, during the initiation and post-initiation phases. Carcinogenesis (Lond.), 16: 2171-2176, 1995.
29. Tanaka, T., Makita, H., Ohnishi, M., Mori, H., Satoh, K., and Hara, A. Chemoprevention of rat oral carcinogenesis by naturally occurring xanthophylls, astaxanthin and canthaxanthin. Cancer Res., 55: 4059-4064, 1995.
30. Havsteen, B. Flavonoids, a class of natural products of high pharmacological potency. Biochem. Pharmacol., 32: 1141-1148, 1983.
31. Leibovitz, B. E., and Mueller, J. A. Bioflavonoids and polyphenols: medical applications J. Optimal Nutr., 2: 17-35, 1993.
32. Kühnau, J. The Flavonoids, a class of semi-essential food components: their role in human nutrition. World Rev. Nutr. Diet., 24: 117-191, 1976.
33. Bjeldans, L. F., and Chang, G. W. Mutagenic activity of quercetin and related compounds Science (Washington DC), 197: 577-578, 1977.
34. Sugimura, T., Nagao, M., Matsushita, T., Yahagi, T., Seino, Y., Shirai, A., Sawamura, M., Natori, S., Yoshihira, K., Fukuoka, M., and Kuroyanagi, M. Mutagenicity of flavone derivatives. Proc. Jpn. Acad. Ser. B. Phys. Biol. Sci., 53: 194-197, 1977.
35. Hatcher, J. F., and Bryan, G. T. Factors affecting the mutagenic activity of quercetin for Salmonella typhimurium TA98: metal ions, antioxidants, and pH. Mutat. Res., 148: 13-23, 1985.
36. Pamukcu, A. M., Yalciner, S., Hatcher, J. F., and Bryan, G. T. Quercetin, a rat intestinal and bladder carcinogen present in bracken fern (Pteridium aquilinum). Cancer Res., 40: 3468-3472, 1980.
37. Erturk, E., Hatcher, J. F., Nunoya, T., and Pamukcu, A. M. Hepatic tumors in Sprague Dawley and Fischer 344 female rats exposed chronically to quercetin or its glycoside rutin. Proc. Am. Assoc. Cancer Res., 25: 95, 1984.
38. Castillo, M. H., Perkins, E., Campbell, J. H., Doerr, R., Hassett, J. M., Kandaswami, C., and Middleton, E. The effects of the bioflavonoids quercetin on squamous cell carcinoma of head and neck origin Am. J. Surg., 158: 351-355, 1989.
39. Scambia, G. Ranelletti, F. O., Benedetti-Panict, P., Piantelli, M., Bonanno, G., Vincenzo, R. D., Ferrandina, G., Rumi, C., Larocca, L. M., and Mancuso, S. Inhibitory effect of quercetin on OVCA 433 cells and presence of type II oestrogen binding sites in primary ovarian tumours and cultured cell Br. J. Cancer, 62: 942-946, 1990.
40. Yoshida, M., Sakai, T., Hosokawa, N., Marui, N., Matsumoto, K., Fujioka, A., Nishino, H., and Aoike, A. The effect of quercetin on cell cycle progression and growth of human gastric cancer cells. FEBS Lett., 260: 10-13, 1990.
41. Scambia, G., Ranelletti, F. O., Benedetti-Panici, P., Piantelh, M., Bonanno, G., Vincenzo, R. D., Ferrandina, G., Pierelli, L., Capelh, A., and Mancuso, S. Quercetin inhibits the growth of a multidrug-resistant estrogen-receptor-negative MCF-7 human breast-cancer cell line expressing type II estrogen-binding sites Cancer Chemother. Pharmacol., 28: 255-258, 1991.
42. Ranelletti, F. O., Ricci, R., Larocca, L. M., Maggiano, N., Capelli, A., Scambia, G., Benedetti-Panici, P., Mancuso, S., Rumi, C., and Piantelli, M. Growth-inhibitory effect of quercetin and presence of type-II estrogen-binding sites in human colon-cancer cell lines and primary colorectal tumors Int. J. Cancer, 50: 486-492, 1992.
43. 1 phase of the cell cycle. Cancer Res., 52: 6676-6681, 1992.
44. Verma, A. K., Johnson, J. A., Gould, M. N., and Tanner, M. A. Inhibition of 7,12-dimethylbenz(a)anthracene- and N-nitrosomethylurea-induced rat mammary cancer by dietary flavonol quercetin Cancer Res., 48: 5754-5758, 1988.
45. Deschner, E. E., Ruperto, J., Wong, G., and Newmark, H. L. Quercetin and rutin as inhibitors of azoxymethanol-induced colonic neoplasia Carcinogenesis (Lond.), 12, 1193-1196, 1991.
46. Kato, R., Nakadate, T., Yamamoto, S., and Sugimura, T. Inhibition of 12-O-tetradecanoyl-phorbol-13-acetate induced tumor promotion and ornithine decarboxylase activity by quercetin, possible involvement of hpoxygenase inhibition Carcinogenesis (Lond.), 4: 1301-1305, 1983.
47. Nakadate, T., Yamamoto, S., Aizu, E., and Kato, R. Effects of flavonoids and antioxidants on 12-0-tetradecanoyl-phorbol-13-acetate-caused epidermal ornithine decarboxylase induction and tumor promotion in relation to lipoxygenase inhibition by these compounds. Gann, 75: 214-222, 1984.
48. Anto, R. J., Sukumaran, K., Kuttan, G., Rao, M. N. A., Subbaraju, V., and Kuttan, R. Anticancer and annoxidant activity of synthetic chalcones and related compounds Cancer Lett., 97: 33-37, 1995.
49. Satomi, Y. Inhibitory effect of 3′-methyl-3-hydroxy-chalcone on proliferation of human malignant tumor cells and on skin carcinogenesis. Int. J Cancer, 55: 506-514, 1993.
50. Ramanathan, R., Das, N. P., and Tan, C. H. Inhibitory effects of 2-hydroxy chalcone and other flavonoids on human cancer cell proliferation Int. J. Oncol., 3: 115-119, 1993.
51. Edenharder, R., von Petersdorff, I., and Rauscher, R. Antimutagenic effects of flavonoids, chalcones and structurally related compounds on the activity of 2-amino-3-methylimidazo[4,5-f]quinoline (IQ) and other heterocyclic amine mutagens from cooked food Mutat Res., 287: 261-274, 1993.
52. Chin, C., and Nagaratnam, P. Cytotoxic effect of butein on human colon adenocarcinoma cell proliferation. Cancer Lett., 82: 65-72, 1994.
53. Yamamoto, S., Aizu, E., Jiang, H., Nakadate, T., Kiyoto, I., Wang, J. C., and Kato, R. The potent anti-tumor-promoting agent isoliquiritigenin. Carcinogenesis (Lond.), 12: 317-323, 1991.
54. Wattenberg, L. W., Coccia, J. B., and Galbraith, A. R. Inhibition of carcinogeninduced pulmonary and mammary carcinogenesis by chalcone administered subsequent to carcinogen exposure. Cancer Lett., 83: 165-169, 1994.
55. Wattenberg, L. W. Chalcones, myo-inositol and other novel inhibitors of pulmonary carcinogenesis. J. Cell. Biochem., 22: 162-168, 1995.
56. Bánóczy, J., and Csiba, A. Occurrence of epithelial dysplasia in oral leukoplakia. Oral Surg., 42: 766-774, 1976.
57. WHO WHO Collaborating Center for Oral Precancerous Lesions, definition of leukoplakia and related lesions: an aid to studies on oral precancer Oral Surg., 46: 518-539, 1978.
58. Koide, T., Sakai, S., Kawada, Y., Hara, A., and Sawada, H. Detection of polyamines by a new enzymatic differential assay 7. Fundamental study on a new enzymatic differential assay of tissue polyamines (in Japanese). Acta Urol. Jpn., 36: 1103-1108, 1990.
59. Ballieul, B., Daubersies, P., Galiègue-Zouitina, S., and Loucheux-Lefebvre, M. H. Molecular basis of 4-nitroquinoline 1-oxide carcinogenesis Jpn. J. Cancer Res., 80: 691-697, 1989.
60. Booth, D. R. A relationship found between intra-oral site of 4NQO reductase activity and chemical carcinogenesis Cell Tissue Kinet., 23: 331-340, 1990.
61. Stanley, J. S., York, L., and Benson, A. M. Nitroreductase and glutathione transferees that act on 4-introquinoline 1-oxide and their differential induction by butylated hydroxyanisole in mice Cancer Res., 52: 58-63, 1992.
62. Ito, N., Hagiwara, A., Tamano, S., Kagawa, M., Shibata, M., Kurata, Y., and Fukushima, S. Lack of carcinogenicity of quercetin in F344/DuCrj rats. Jpn. J. Cancer Res., 80: 317-325, 1989.
63. Hirono, I., Ueno, I., Hosaka, S., Takahashi, H., Matsushima, T., Sugimura, T., and Natori, S. Carcinogenicity examination of quercetin and rutin in ACI rats Cancer Lett., 13: 15-21, 1981.
64. Das, M., Mukhtar, H., Bik, D. P., and Bickers, D. R. Inhibition of epidermal xenobiotic metabolism in SENCER mice by naturally occurring plant phenols. Cancer Res., 47: 760-766, 1987.
65. Elangovan, V., Sekar, N., and Govindasamy, S. Chemopreventive potential of dietary bioflavonoids against 20-methylcholanthrene-induced tumorigenesis Cancer Lett., 87: 107-113, 1994.
66. Fernola, P., Cody, V., and Middleton, E. J. Protein kinase C inhibition by plant flavonoids: kinetic mechanisms and structure-activity relationships. Biochem. Pharmacol., 38: 1617-1624, 1989.
67. Ueno, I., Nakano, N., and Hirono, I. Metabolic fate of [C]quercetin in the ACI rat. Jpn. J Exp Med., 53: 41-50, 1983.
68. Sogawa, S., Nihro, Y., Ueda, H., Izumi, A., Miki, T., Matsumoto, H., and Satoh, T. 3.4-Dyhidroxychalcones as potent 5-lipoxygenase and cyclooxygenase inhibitors. J. Med. Chem., 36: 3904-3909, 1993.
69. Wattenberg, L. W. Inhibition of carcinogenesis by nonnutrient constituents of the diet In: K. W. Waldron, I. T. Johnson, and G. R. Fenwick (eds.), Food and Cancer Prevention: Chemical and Biological Aspects, pp. 12-23. Norwich, England: Royal Society of Chemistry, 1992.
70. Stavric, B. Quercetin in our diet: from potent mutation to probable anticarcinogen. Clin. Biochem., 27: 245-248, 1994.